Nerve growth factor and Alzheimer's disease

Area of Science:

• Neuroscience
• Neurodegenerative Diseases
• Pharmacology

Background:

• Alzheimer's disease (AD) is characterized by cholinergic neuron atrophy in the basal forebrain.
• Nerve growth factor (NGF) influences cholinergic neurons, suggesting therapeutic potential for AD.

Purpose of the Study:

• To review the role of NGF in Alzheimer's disease.
• To evaluate the potential of NGF as a therapeutic agent for AD-related neurodegeneration and cognitive deficits.

Main Methods:

• Review of existing literature on NGF, its receptors, and their localization in the central nervous system.
• Synopsis of AD neuropathology and relevant studies on NGF and its receptor levels in AD brains.

Main Results:

• NGF and its low-affinity receptor are present in the AD brain.
• Cortical NGF levels may increase in AD, questioning the direct link between endogenous NGF and cholinergic atrophy.
• Evidence suggests NGF's role in maintaining basal forebrain cholinergic neurons.

Conclusions:

• The precise role of NGF in AD pathogenesis remains unclear.
• Further research is needed to determine NGF's therapeutic efficacy for AD.
• Human studies are necessary to investigate NGF distribution and its relationship with neuronal status in AD before clinical trials.